SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Background: About 1.5 million adults in the US enter alcohol or substance use treatment programs each year. Unfortunately, more than half of patients do not finish their program.
Official registry: https://clinicaltrials.gov/study/NCT06676059 · National Institute on Drug Abuse (NIDA) · enrollment listed as 10,000
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 10,000 people at Baltimore. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Primary outcome (registry wording): SMARTr data repository
Who it is for (from inclusion criteria)
- Ages 18 Years to 120 Years
- In order to be eligible to participate in the repository, an individual must meet all of the following criteria:
- Be an adult aged 18 or older
- Self-report alcohol or other drug use within the past 30 days
- Have a smartphone as their primary mobile phone
- Understand and write in English
- Live in the United States
Who the registry excludes
- An individual who meets any of the following criteria will be excluded from participation in this repository:
Public study contact (from the registry)
Jessica E Hemmons
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
1 listed- National Institute on Drug Abuse — Baltimore, Maryland (recruiting)
FAQ about this NCT record
Is NCT06676059 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT06676059?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT06676059?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary